Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease
Mitral valve disease (MVD) is a frequent cause of heart failure and death worldwide, but its etiopathogenesis is not fully understood. Interleukin (IL)-33 regulates inflammation and thrombosis in the vascular endothelium and may play a role in the atherosclerotic process, but its role in mitral valv...
Main Authors: | Amaia Garcia-Pena, Jaime Ibarrola, Adela Navarro, Alba Sadaba, Carolina Tiraplegui, Mattie Garaikoetxea, Vanessa Arrieta, Lara Matilla, Amaya Fernández-Celis, Rafael Sadaba, Virginia Alvarez, Alicia Gainza, Eva Jover, Natalia López-Andrés |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/5/2310 |
Similar Items
-
Genomic analysis in patients with myxomatous mitral valve prolapse: current state of knowledge
by: S. Gasser, et al.
Published: (2018-02-01) -
Myxomatous Mitral Valve Disease with Mitral Valve Prolapse and Mitral Annular Disjunction: Clinical and Functional Significance of the Coincidence
by: Nina C. Wunderlich, et al.
Published: (2021-01-01) -
Advances in the understanding of the pathogenesis, progression and diagnosis of myxomatous mitral valve disease in dogs
by: Richard K. Burchell, et al.
Published: (2014-08-01) -
Asymptomatic Myxomatous Degeneration of the Mitral Valve, in a Young Male
by: Opris Carmen, et al.
Published: (2020-12-01) -
Mitral annulus dynamics in myxomatous mitral valve disease
by: Maria-Magdalena Gurzun, et al.
Published: (2021-03-01)